Oct 20, 2020 / 02:00PM GMT
Operator
Ladies and gentlemen, hello, and welcome to the Epigenomics AG conference call regarding preliminary CMS decision. (Operator Instructions)
Let me now turn the floor over to your host, Mr. Frederic Hilke.
Frederic Hilke - Epigenomics AG - IR Officer
Thank you very much, Elena. Hello, and welcome to Epigenomics investor conference call. My name is Frederic Hilke. I'm the Investor Relations Manager for Epigenomics. With me on the phone is the CEO of Epigenomics AG, Greg Hamilton; and President and CFO, Dr. Jorge Garces.
On today's call, we will be discussing the CMS proposed NCD and preliminary Q3 results. This call is being webcast for anyone who would like to follow the presentation. The link can be found on the Epigenomics website in the financial calendar.
Before I hand over the presentation to Greg, let me point out some of the usual legal information. The following presentation will contain expressly or implicitly certain forward-looking statements concerning Epigenomics AG and its business. Such statements involve certain known
Epigenomics AG - Special Call Transcript
Oct 20, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers